Number of the records: 1
eptifibatid
SYS d000077542 LBL 00000cx^^^2200181-^^45^^ 005 20240119195330.0 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a eptifibatid $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (1994) $8 eng 330 1-
$a Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures. $8 eng 450 $a 7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)- $5 e $8 eng 450 $a epifibratid $5 e $8 slo 450 $a epifibatid $5 e $8 slo 450 $a integrilín $5 e $8 slo 450 $a integrelín $5 e $8 slo 686 $a D12.644.641.366 750 $a Eptifibatide $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190502 801 -2
$a SK $b BA006 $c 20200820 980 $x M
Number of the records: 1